Courses   Wikipedia   PubMed   Dictionary  
Username:
Password:
 
Create a CME-TODAY Account
Free Subscription
 You are here:   Physician Assistants  >>   Program CD0117  >>   Course AB0493
ACCREDITATION
SUPPORTER INFORMATION
CERTIFICATE FEES
PRINTABLE RESOURCES
You will need:

Using Spirometry Effectively as a Diagnostic Tool
Feedback
FAQ

 


Faculty:  Susan B. Blonshine, RRT, RPFT, FAARC, AE-C

This instructive interactive course demonstrates how to correctly perform spirometry and discusses what results you should expect and how to interpret them.

New! Video on Spirometry Techniques
Click here to watch a clinician explain and conduct spirometry with a patient.


To take this course choose your format at the bottom of this page.

Key Words: Chronic Obstructive Pulmonary Disease, COPD, Spirometry, Screening
OVERVIEW
The patient’s history and physical examination are the essential first steps for identifying chronic obstruction pulmonary disease (COPD). However, spirometry is the gold standard for confirming the diagnosis of COPD. Spirometry is a simple and cost-effective test that can be used in both outpatient and inpatient settings to initially diagnose COPD, to assess treatment responses, and to monitor disease progression over time. All healthcare professionals who care for patients with COPD should have access to spirometry or to a referral center where spirometry can be performed. This instructive interactive course demonstrates how to correctly perform spirometry and discusses what results you should expect and how to interpret them.
[Top]
OBJECTIVES
Upon completion of this course, you should be able to:
 
  • Describe the steps to perform an accurate spirometry

  • Interpret normal versus obstructive patterns

[Top]
 
TARGET AUDIENCE
This CME activity is designated for physician assistants who treat patients with COPD.
[Top]
FACULTY
 
Susan B. Blonshine, RRT, RPFT, FAARC, AE-C  [BioSketch]
CEO and President TechEd Consultants, Inc.
Technical Director Michigan State University Pediatric Pulmonary Function Laboratory
Disclosure: Consultant: Mannkind Corp.
CONTRIBUTING FACULTY
 
Timothy D. Byrum, CRNP  [BioSketch]
Clinical Assistant Professor University of Alabama Huntsville, AL
Disclosure: Speaking honoraria: GlaxoSmithKline, Pfizer Inc.
John Hollingsworth, PA-C, RRT  [BioSketch]
Physician Assistant, Allergy Associates Medical Group, Inc., San Diego, CA
Disclosure: Speaking honoraria: AstraZeneca, Schering-Plough
[Top]
CONFLICT OF INTEREST RESOLUTION

MEBN provides education approved by the AANP, AAPA, AARC, AAFP, CCMC and others, as well as being accredited to provide CME/CE by the ACCME, ACPE and ANCC through NHNA. Therefore, MEBN must ensure balance, independence, objectivity and scientific rigor in all of its educational activities. All faculty participating in these activities are expected to disclose any or no relevant financial interest or other relationship with (1) the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in any educational presentation, and/or (2) with any commercial supporters of an activity. Disclosure of any or no relationship(s) will be listed prior to any educational activity.

All apparent conflicts of interest have been identified and resolved through MEBN’s independent, peer-review process. Our intent is to assist learners in assessing the potential for bias in information that is presented during the educational activity. The faculty are also aware of their responsibility to inform the audience if discussion of any non-FDA-approved uses of pharmaceuticals, medical equipment, prostheses, etc. will be included in their presentation.

Unless otherwise indicated, MEBN staff and writers have no financial relationships with a commercial party to disclose.

[Top]
 
ACCREDITATION STATEMENT

Continuing Medical Education for Physician Assistants  

This program has been reviewed and is approved for a maximum of 0.5 hour(s) of AAPA Category I (Preapproved) CME credit by the Physician Assistant Review Panel. Approval is valid for one year from the issue date of March 31, 2008. Participants may submit the self-assessment at any time during that period.

This program was planned in accordance with AAPA's CME Standards for Enduring Material Programs and for Commercial Support of Enduring Material Programs.

[Top]
 
DISCLAIMER

Disclaimer
This continuing education program may contain discussion of published and/or investigational uses of agents or products that are not approved by the Food and Drug Administration (FDA). The authors, sponsors or publishers do not recommend the use of any agent or product outside of the official labeled indications. Please refer to the official prescribing information for each agent or product for discussion of approved indications, contraindications, and written warnings.

Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this course should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

The authors, contributors, and editorial staff have made every effort to contact holders of copyright to obtain permission to reproduce copyright material. However, if any permissions have been inadvertently overlooked, MEBN will be pleased to make the necessary and reasonable arrangements.

[Top]
How to Take This Course
Important Note: Successful completion of the self-assessment is required to earn Category I CME credit. Successful completion is defined as a cumulative score of at least 70% correct.

Choose Your Format To Begin Course:   


Audio
 
Multimedia
 
Podcast
 
Transcript
 
[Top]
 
SUPPORTER INFORMATION
Supported by an educational grant from
 

http://us.boehringer-ingelheim.com/ www.pfizer.com
[Top]
 
CERTIFICATE FEES

CME-TODAY offers FREE continuing medical education (CME) credits to recipients of the CD-ROM, program emails or CME-TODAY journal. Enter the the CE Code listed on the CD-ROM, in the email or in the journal when prompted. This free offer expires on March 31, 2009. All others will be assessed a $6.00 processing fee.

[Top]